… a Business Update Key updates Major progress in the QR-010 development program for CF with presentation of positive … in our NPD biomarker study, showing clinically meaningful drug activity in homozygous F508del CF patients, we look … We believe that James’ broad knowledge and expertise in drugdevelopment and pharma will be of significant value to …